Letter from the President 2013-2015

By Jamil Abdalla Saad
SOLACI President.  

Dear friends and colleagues, 

With great honor, we assume the SOLACI presidency for 2013-2015. The commitment to exercising command on a continental society, succeeding three illustrious predecessors, is always a challenge and this time is renewed in observing Brazil. The governing board is completed by Ricardo Lluberas MD (Uruguay – Vice President), José Luis Leiva Pons MD (Mexico – Secretary), and Jose Alvarez MD (Argentina – treasurer), along with the corresponding regions’ designated members. 

With enthusiasm, confidence, teamwork, and tolerance, we expect to exceed our regional communication differences as well as celebrate our union. The effort started in previous administrations left us a legacy of exchanges and reciprocal relationships with major international cardiology societies: ACC, TCT-CRF (Transcatheter Therapeutics), SCAI (Interventional Cardiology of America), and Euro-PCR. Although these relationships are well established, there will always be room for consolidation and improvement. 

Expanding the presence, even in remote regions, scientific updates especially at a distance and making records on specific issues will be a priority in the mandate. What is even more outstanding is the still great interest of clinical cardiologists in participating in our events, which is an essential point for the universal access of all patients to the most current treatments available to treat their diseases and the ultimate goal of all specialty societies.

All of this will be possible only with the intense participation and integration of our partners in all of our activities. Join us in this noble effort and ideal for many. 

SOLACI

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...